Skip to content

The role of intravenous Lidocain as sedative and analgesic for the reduction of anterior shoulder dislocation in refereed to Emergency ward of hospital

The Comparison of intravenous Midazolam, Fentanyl versus intravenous Lidocain, Midazolam and Fentanyl as sedative and analgesic for the reduction of anterior shoulder dislocation in patient presented to Emergency Department

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016101730353N1
Enrollment
100
Registered
2017-02-12
Start date
2015-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anterior shoulder dislocation. Anterior subluxation and dislocation of humerus

Interventions

Intervention 1: In control grup, after pain assesment, patients were gave 5 cc intravenus distilled water. After 5 minute the patients were gave titrate intravenus Midazolam & Fentanyl to reach 4 fro
Treatment - Drugs
In control grup, after pain assesment, patients were gave 5 cc intravenus distilled water. After 5 minute the patients were gave titrate intravenus Midazolam & Fentanyl to reach 4 from ramsay score.
In intervention group, after pain assesment, patients were gave intravenus lidocain 1 mg per kg of patient body weight. After 5 minute the patients were gave titrate intravenus Midazolam & Fentanyl to

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients with anterior shoulder dislocation Exclusion criteria: All patients with loss of consciousness; the patient who has shoulder fracture(except hill-sachs lesion); past medical history of shoulder surgery or shoulder fracture; past medical history of epilepsy; cardiac disease or dysrhythmia drug history of using digoxin; all patient with allergy to lidocain midazolam or fentanyl

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of pain. Timepoint: before sedation and after full conciousnes. Method of measurement: according to VAS (Visual Analog Scale).

Secondary

MeasureTime frame
Drug`s side effects: apnea, oxigen saturation decrease less than 90 percent, dysrhytmia, other. Timepoint: after full consciousness. Method of measurement: questionair.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAida Mohammadian

Immam Hosein hospital

aynaz3139@gmail.comaidamohammadian@yahoo.com+98 21 7755 8081

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026